Know Your IPO: GoodRx, Digging Into Nike's Earnings & Anaplan CEO

The Dow closed down 525 points, swinging 680+ points, and Jim Cramer is helping investors navigate the ongoing bear market. Then, as the wave of public offerings continues, Cramer's taking a closer look at today's IPO GoodRx and how it might fit into your portfolio. Next, as the aftershocks of Nike's better-than-expected earnings continue to shake up the market, what should investors do with the stock as it hits all-time highs? Cramer's digging deeper into the call and where to go from here. Plus, Cramer's exclusive with Anaplan CEO Frank Calderoni.